skip navigation

Skip Nav

Clinical Guidelines Portal

skip navigation

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Bacterial Respiratory

(Last updated:11/1/2012; last reviewed:11/1/2012)

Bacterial Respiratory
Member Financial Disclosure
Company Relationship
Crothers, Kristina
Yale University School of Medicine None N/A
Huang, Laurence*
University of California San Francisco
MiniVax Consultant
Miller, Robert
University College London, England
BMJ Publishing Group
Honoraria
Gilead Honoraria, Speaker’s Bureau
Mark Allen Healthcare 
Honoraria
Merck Honoraria, Speaker’s Bureau
National Institutes of Health
Research Support
Moore, Matthew
Centers for Disease Control and Prevention
None N/A
Morris, Alison
University of Pittsburgh Medical School
Cape Cod Association
Research Support
Gilead Research Support
NIH Research Support
Roche Research Support
Niederman, Michael
Winthrop University Hospital
Bayer Honoraria, Research Support
Cubist Research Support
GlaxoSmithKline
Advisory Board
Johnson & Johnson
Advisory Board, Honoraria
Merck Advisory Board, Honoraria
Paratek Advisory Board
Pfizer Advisory Board, Honoraria
Sanofi-Pasteur
Advisory Board, Research Support
Schering Plough
Advisory Board, Research Support
*Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.